125
Participants
Start Date
September 28, 2022
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2026
Mirvetuximab soravtansine
Mirvetuximab Soravtansine (MIRV) is an investigational antibody drug conjugate designed to selectively kill cancer cells. The antibody (protein) part of MIRV targets tumors by delivering a cell-killing drug to the tumor cells carrying a tumor-associated protein called FRα. It is being developed for the treatment of participants with recurrent platinum-sensitive, high grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with FRα expression. FRα positivity will be defined by the Ventana FOLR1 Assay.
Carboplatin
Carboplatin is considered to be the treatment agent of choice in relapsed PSOC.
Cliniques Universitaires UCL Saint-Luc /ID# 268916, Brussels
Universitair Ziekenhuis Leuven /ID# 268914, Leuven
Duplicate_CHU de Liege /ID# 268918, Liège
Columbia University Irving Medical Center /ID# 268887, New York
Long Island Jewish Medical Center /ID# 268909, New Hyde Park
Hospital Universitario Reina Sofia /ID# 269657, Córdoba
Complejo Hospitalario Universitario A Coruña /ID# 268930, A Coruña
Hospital Universitario Arnau de Vilanova de Lleida /ID# 268939, Lleida
University of North Carolina Medical Center /ID# 268963, Chapel Hill
Duke Cancer Center Macon Pond /ID# 268910, Raleigh
Clinica Universidad de Navarra - Madrid /ID# 268935, Madrid
Hospital Universitario Fundación Jiménez Díaz /ID# 268938, Madrid
Hospital Universitario 12 de Octubre /ID# 268936, Madrid
Hospital Universitario HM Sanchinarro /ID# 268932, Madrid
MUSC Hollings Cancer Center /ID# 268892, Charleston
Winship Cancer Institute of Emory University /ID# 268913, Atlanta
Clinica Universidad de Navarra - Pamplona /ID# 268940, Pamplona
AdventHealth Orlando /ID# 268920, Orlando
Moffitt Cancer Center /ID# 269089, Tampa
Sarasota Memorial Hospital /ID# 268882, Sarasota
Hospital Clínico Universitario de Valencia /ID# 268933, Valencia
Karmanos Cancer Institute - Detroit /ID# 268890, Detroit
Washington University School of Medicine - St. Louis /ID# 268897, St Louis
Women'S Cancer Care /ID# 268898, Covington
Ou Health - Stephenson Cancer Center /ID# 268878, Oklahoma City
University of Texas - Southwestern Medical Center /ID# 268891, Dallas
University of Arizona Cancer Center /ID# 268906, Tucson
University of New Mexico Comprehensive Cancer Center /ID# 268961, Albuquerque
Presbyterian Rust Medical Center /ID# 278582, Rio Rancho
The Center Of Hope /ID# 268884, Reno
University of Southern California /ID# 268964, Los Angeles
University of California Los Angeles Medical Center /ID# 268883, Los Angeles
Moores Cancer Center /ID# 268888, La Jolla
Scripps Md Anderson - Prebys Cancer Center /ID# 268966, San Diego
Hoag Memorial Hospital Presbyterian /ID# 268907, Newport Beach
Women'S Cancer Research Network - Cogi /ID# 268912, Fresno
California Pacific Medical Center - Van Ness Campus /ID# 268886, San Francisco
UC Davis Comprehensive Cancer Center /ID# 269085, Sacramento
Duplicate_Kadlec Clinic Heme-Onc /ID# 268580, Kennewick
Providence - St. Jude Medical /ID# 268911, Fullerton
Smilow Cancer Hospital at Yale New Haven /ID# 268889, New Haven
Northwestern University- Robert H. Lurie Comprehensive Cancer Center /ID# 268957, Chicago
Massachusetts General Hospital /ID# 268879, Boston
Dana-Farber Cancer Institute /ID# 268881, Boston
Md Anderson Cancer Center At Cooper /ID# 268885, Camden
Holy Name Medical Center /ID# 268903, Teaneck
Women & Infants Hospital /ID# 268895, Providence
BC Cancer - Vancouver /ID# 268901, Vancouver
Universite de Montreal - Hopital Maisonneuve-Rosemont /ID# 268902, Montreal
Centre Hospitalier De L'Universite De Montreal - Hopital Saint-Luc /ID# 268899, Montreal
McGill University Health Centre - Glen Site /ID# 269084, Montreal
Centre Hospitalier Universite De Sherbrooke - Hôtel-Dieu Hospital /ID# 268900, Sherbrooke
American Hospital Tbilisi /ID# 268947, Tbilisi
High Technology Hospital MedCenter /ID# 268946, Tbilisi
Israeli-Georgian Medical Research Clinic Helsicore /ID# 268950, Tbilisi
Caraps Medline /ID# 268948, Tbilisi
Duplicate_Consilium Medulla Multiprofile Clinic /ID# 268951, Tbilisi
Institut Català d'Oncologia (ICO) - Badalona /ID# 268929, Badalona
Complejos Hospitalario Universitario de Badajoz /ID# 268937, Badajoz
Usp Instituto Universitario Dexeus /ID# 268931, Barcelona
Hospital Universitario Vall de Hebron /ID# 268926, Barcelona
Hammersmith Hospital /ID# 268945, London
Guy's Hospital /ID# 269083, London
The Royal Marsden - Chelsea /ID# 268943, London
Mount Vernon Hospital /ID# 268942, Northwood
Nottinghamshire Healthcare NHS Foundation Trust /ID# 269087, Nottingham
Musgrove Park Hospital /ID# 269088, Taunton
The Royal Marsden - Sutton /ID# 268941, Sutton
The Christie /ID# 268944, Manchester
Lead Sponsor
AbbVie
INDUSTRY